Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 21, 2017; 23(19): 3546-3555
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3546
Table 1 Baseline demographics, clinical characteristics and proportions for laparoscopic Nissen fundoplication and proton pump inhibitor groups
Characteristic/parameterLNFPPIP value
No.3139
Age (yr)47.2 ± 10.751.3 ± 12.50.218
Sex0.670
Male14 (45.2)19 (48.7)
Female17 (54.8)20 (51.3)
BMI (kg/m2)23.9 ± 3.825.0 ± 3.10.285
RSI score15.3 ± 3.514.2 ± 4.00.759
Presenting complaint
Regurgitation121 (67.7)26 (66.7)0.926
Heartburn123 (74.2)28 (71.8)0.826
Cough18 (58.1)21 (53.8)0.729
Mucus14 (45.1)12 (30.7)0.222
Globus27 (87.1)20 (51.3)0.0032
Hoarseness12 (38.7)10 (25.6)0.248
Throat pain12 (38.7)10 (25.6)0.248
Throat clearing10 (32.2)9 (23.1)0.398
Table 2 Characteristics on the oropharyngeal pH-monitoring, manometry and endoscopy between laparoscopic Nissen fundoplication and proton pump inhibitor groups
Characteristic/examination parameterLNFPPIP value
Oropharyngeal pH-monitoring
Acid exposure (upright, %)11.77 ± 18.958.49 ± 15.660.416
Acid exposure (supine, %)4.25 ± 12.793.28 ± 7.920.182
Number of reflux events (upright)53.84 ± 97.4834.93 ± 65.350.195
Number of reflux events (supine)7.44 ± 18.425.14 ± 9.220.232
Ryan score (upright)335.13 ± 491.08274.57 ± 459.100.617
Ryan score (supine)8.98 ± 16.187.23 ± 7.810.217
High-resolution Manometry
LES pressure (mmHg)11.78 ± 8.0714.84 ± 9.730.236
UES pressure (mmHg)43.8 ± 28.3367.08 ± 42.510.0451
Dysperistalsis3 (9.7)10 (25.6)0.0901
Hiatal hernia24 (77.4)33 (84.6)0.449
GI endoscopy
Esophagitis (grade A)10 (32.2)10 (25.6)0.549
Esophagitis (grade B)3 (9.7)2 (5.1)0.470
Hiatal hernia16 (51.6)30 (76.9)0.0271
Table 3 Comparison of the laryngopharyngeal and gastroesophageal reflux disease typical symptom score between laparoscopic Nissen fundoplication and proton pump inhibitor groups before treatment and at 6-mo and 2-year follow-up
Characteristic/symptom score (No. of LNF/PPI)Baseline (n = 70)
6-mo follow-up (n = 61)
2-yr follow-up (n = 53)
LNFPPIP valueLNFPPIP valueLNFPPIP value
Regurgitation2 (17/20)6.47 ± 0.626.24 ± 0.560.3851.41 ± 1.692.53 ± 1.150.02211.12 ± 1.472.53 ± 1.260.0051
Heartburn2 (19/20)6.33 ± 0.686.30 ± 0.590.1001.33 ± 1.062.60 ± 1.690.00810.94 ± 1.103.05 ± 2.200.0011
Cough (15/16)7.71 ± 0.827.67 ± 0.460.8042.34 ± 2.374.40 ± 2.100.02212.28 ± 2.125.00 ± 2.280.0121
Mucus (11/9)7.09 ± 0.837.22 ± 0.440.8242.82 ± 2.244.77 ± 1.850.05513.27 ± 2.185.29 ± 1.780.0201
Globus (23/14)6.10 ± 0.667.01 ± 0.880.2682.95 ± 2.755.43 ± 2.500.01312.77 ± 2.875.28 ± 2.860.0171
Hoarseness (10/7)7.30 ± 2.787.33 ± 2.550.9543.80 ± 2.695.00 ± 2.650.4093.50 ± 2.764.33 ± 2.530.546
Throat pain (11/4)7.20 ± 1.037.50 ± 0.580.5523.70 ± 2.985.50 ± 2.650.1003.20 ± 3.464.25 ± 2.060.166
Throat clearing (6/7)7.67 ± 0.527.14 ± 0.520.0633.33 ± 2.066.00 ± 1.530.03412.83 ± 2.406.28 ± 1.510.0201
Table 4 Comparison of outcome between laparoscopic Nissen fundoplication and proton pump inhibitor administration by 2-year follow-up
Characteristic/parameterLNF (n = 25)PPI (n = 28)P value
BMI (kg/m2)
Pre-treatment24.9 ± 3.825.0 ± 3.10.285
Post-treatment22.2 ± 3.1225.1 ± 2.90.0011
RSI score (value)
Pre-treatment15.3 ± 3.514.2 ± 4.00.759
Post-treatment9.7 ± 4.1212.8 ± 3.120.0041
RSI score (≥ 13), n (%)
Pre-treatment19 (76.0)24 (85.7)0.284
Post-treatment7 (28.0)219 (67.9)20.0031
PPI independence, n (%)11(44.0)2 (7.14)0.0001
Satisfaction, n (%)62.49 ± 28.6844.36 ± 32.770.0041